Capecitabine Mylan 150 mg Filmdragerad tablett

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Bipacksedel Bipacksedel (PIL)
20-04-2018
Produktens egenskaper Produktens egenskaper (SPC)
20-04-2018

Aktiva substanser:

kapecitabin

Tillgänglig från:

Mylan S.A.S.

ATC-kod:

L01BC06

INN (International namn):

capecitabine

Dos:

150 mg

Läkemedelsform:

Filmdragerad tablett

Sammansättning:

kapecitabin 150 mg Aktiv substans

Klass:

Apotek

Receptbelagda typ:

Receptbelagt

Terapiområde:

Kapecitabin

Bemyndigande status:

Avregistrerad

Tillstånd datum:

2012-11-16

Bipacksedel

                                PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CAPECITABINE MYLAN 150 MG FILM-COATED TABLETS
CAPECITABINE MYLAN 500 MG FILM-COATED TABLETS
capecitabine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Capecitabine Mylan is and what it is used for
2.
What you need to know before you take Capecitabine Mylan
3.
How to take Capecitabine Mylan
4.
Possible side effects
5.
How to store Capecitabine Mylan
6.
Contents of the pack and other information
1.
WHAT CAPECITABINE MYLAN IS AND WHAT IT IS USED FOR
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 150 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 500 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan is used in the treatment of colon, rectal, gastric,
or breast cancers.
Furthermore, Capecitabine Mylan is used to prevent new occurrence of
colon cancer after complete
removal of the tumour by surgery.
Capecitabine Mylan may be used either alone or in combination with
other medicines.
2.
WHAT Y
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 02-06-2015
Produktens egenskaper Produktens egenskaper engelska 22-10-2014
Offentlig bedömningsrapport Offentlig bedömningsrapport engelska 28-01-2013